Calcium is not required for 5-lipoxygenase activity at high phosphatidyl choline vesicle concentrations

被引:25
|
作者
Skorey, KI [1 ]
Gresser, MJ [1 ]
机构
[1] Merck Frosst Canada Inc, Merck Frosst Ctr Therapeut Res, Dept Biochem & Mol Biol, Pointe Claire, PQ H9R 4P8, Canada
关键词
D O I
10.1021/bi980371g
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
5-Lipoxygenase (5-LO) catalyzes the formation of 5-hydroperoxy-eicosatetraenoic acid (5 HPETE) and leukotriene A(4) (LTA(4)) from arachidonic acid. Following a rise in intracellular calcium, 5-LO translocates to a membrane where it reacts with arachidonic acid via an 18 kD protein (FLAP). In vitro studies using a vesicle system of phosphatidylcholine (PC) and purified 5-LO were conducted under varying concentrations of PC and calcium. At high PC concentrations, 5-LO partitioned onto the vesicle containing arachidonic acid, resulting in product formation in the absence of calcium. Addition of calcium increased the initial rate of the reaction with a small increase in product accumulation. Dilution experiments in the absence of calcium at high PC concentrations indicated that binding of 5-LO to the vesicles is rapidly reversible. In the presence of calcium, this binding is much more favorable than without calcium. Stimulation of 5-LO activity by dithiothreitol (DTT) was more pronounced at high PC concentrations than at low PC concentrations. The requirement for ATP for maximal activity was independent of vesicle concentration. Inhibitors that functioned in the conditions of low PC with calcium present also inhibited under high PC without calcium. In the presence of PC and calcium and without substrate, the enzyme was unstable and was rapidly and irreversibly inactivated. In high PC without calcium, the enzyme was much more stable but it was still subject to turnover-dependent inactivation. Fluorescence energy-transfer experiments confirmed the kinetic findings that 5-LO could bind to the vesicle in the absence of calcium. These results show that in the absence of calcium, 5-LO can reversibly bind to the vesicle containing arachidonic acid and produce the same amount of product by a similar mechanism as observed with low PC and calcium. Calcium likely causes a conformational change that increases the affinity of the enzyme for the vesicle, but it is not strictly required for enzymatic activity and has no effect on the function of the catalytic site.
引用
收藏
页码:8027 / 8034
页数:8
相关论文
共 50 条
  • [1] INTRINSIC 5-LIPOXYGENASE ACTIVITY IS REQUIRED FOR NEUTROPHIL RESPONSIVITY
    GUIDOT, DM
    REPINE, MJ
    WESTCOTT, JY
    REPINE, JE
    PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1994, 91 (17) : 8156 - 8159
  • [2] Calcium binding to 5-lipoxygenase
    Hammarberg, T
    Reddy, KV
    Persson, B
    Rådmark, O
    EICOSANOIDS AND OTHER BIOACTIVE LIPIDS IN CANCER, INFLAMMATION, AND RADIATION INJURY, 5, 2002, 507 : 117 - 121
  • [3] 5-lipoxygenase binds calcium
    Hammarberg, T
    Rådmark, O
    BIOCHEMISTRY, 1999, 38 (14) : 4441 - 4447
  • [4] INFLUX OF EXTRACELLULAR CALCIUM IS REQUIRED FOR THE MEMBRANE TRANSLOCATION OF 5-LIPOXYGENASE AND LEUKOTRIENE SYNTHESIS
    WONG, A
    COOK, MN
    FOLEY, JJ
    SARAU, HM
    MARSHALL, P
    HWANG, SM
    BIOCHEMISTRY, 1991, 30 (38) : 9346 - 9354
  • [5] Calcium binding site of 5-lipoxygenase
    Hammarberg, T
    Provost, P
    Reddy, KV
    Persson, B
    Rådmark, O
    ADVANCES IN PROSTAGLANDIN AND LEUKOTRIENE RESEARCH: BASIC SCIENCE AND NEW CLINICAL APPLICATIONS, 2001, 16 : 17 - 20
  • [6] 5-LIPOXYGENASE ACTIVITY IN ATHEROSCLEROTIC PLAQUES
    DECATERINA, R
    MAZZONE, A
    GIANNESSI, D
    SICARI, R
    PELOSI, W
    LAZZERINI, G
    ARTERIOSCLEROSIS, 1987, 7 (05): : A531 - A531
  • [7] 5-LIPOXYGENASE ACTIVITY IN THE HUMAN PANCREAS
    MANCINI, JA
    LI, C
    VICKERS, PJ
    JOURNAL OF LIPID MEDIATORS, 1993, 8 (03): : 145 - 150
  • [8] Regulation of 5-lipoxygenase enzyme activity
    Rådmark, O
    Samuelsson, B
    BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, 2005, 338 (01) : 102 - 110
  • [9] 5-LIPOXYGENASE INHIBITORY ACTIVITY OF ZILEUTON
    CARTER, GW
    YOUNG, PR
    ALBERT, DH
    BOUSKA, J
    DYER, R
    BELL, RL
    SUMMERS, JB
    BROOKS, DW
    JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS, 1991, 256 (03): : 929 - 937
  • [10] Nonredox 5-lipoxygenase inhibitors require glutathione peroxidase for efficient inhibition of 5-lipoxygenase activity
    Werz, O
    Szellas, D
    Henseler, M
    Steinhilber, D
    MOLECULAR PHARMACOLOGY, 1998, 54 (02) : 445 - 451